Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AMBISOME
- Bioequivalence of Amphotericin B Liposome for Injection
- Pharmacokinetics and Safety of AmBisome and DKF-5122
- Olorofim Aspergillus Infection Study
- A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects
- Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)
- Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole
- Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
- Short Course Regimens for Treatment of PKDL (Sudan)
- Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
- Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)
- Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
- Liposomal Amphotericin in Disseminated Leishmaniasis
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
- Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
- An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects
- Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
- SCH708980 With and Without AmBisome for Visceral Leishmaniasis
- Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
- Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
- Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
- Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients
- Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
- Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
- Liver Transplant European Study Into the Prevention of Fungal Infection
- Antifungal Locks to Treat Fungal-related Central Line Infections
- High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
- To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
- Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
- Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients
- Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
- CRITIC - Treatment of Candidemia and Invasive Candidiasis
- Sodium Stibogluconate Treatment of Leishmaniasis
- Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
- Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
- Combination Therapy in Indian Visceral Leishmaniasis
- Antimicrobial PK in Infants With Suspected or Confirmed Infection
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment
- Intermittent Liposomal Amphotericin B Primary Prophylaxis
- Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
- Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
- Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis
- ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
- Combination Chemotherapy for the Treatment of Indian Kala-Azar
- PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia
- Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
- COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis
- PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation
- Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
- Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
- Ambisome in Liver Transplant Patients
- Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment
- Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia
- Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
- Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
- Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants
Clinical trials list
click for details